Ivana Ježíšková

Monitoring of minimal residual disease in acute myeloid leukemia with frequent and rare patient‐specific <i>NPM1</i> mutations

Dana Dvořáková, Zdeněk Ráčil, Ivana Ježíšková et al. · American Journal of Hematology · 2010 · 39 citations · Full text

Detection and treatment of molecular relapse in acute myeloid leukemia with RUNX1 (AML1), CBFB, or MLL gene translocations: Frequent quantitative monitoring of molecular markers in different compartments and correlation with WT1 gene expression

Michael Doubek, Ivo Palásek, Zdeněk Pospı́šil et al. · Experimental Hematology · 2009 · 32 citations

Hematological Malignancy, Molecular Relapse, Molecular Markers +11

Increasing hematopoietic microchimerism is a reliable indicator of incipient AML relapse

Ondřej Horký, Jiřı́ Mayer, Lenka Kablásková et al. · International Journal of Laboratory Hematology · 2010 · 24 citations

Distribution of mutations in DNMT3A gene and the suitability of mutations in R882 codon for MRD monitoring in patients with AML

Ivana Ježíšková, Milena Musilová, Martin Čulen et al. · International Journal of Hematology · 2015 · 18 citations

Chromatin, Dnmt3a Gene, Genetic Disorder +9

Clonal hierarchy of main molecular lesions in acute myeloid leukaemia

Zdeňka Herudková, Martin Čulen, Adam Folta et al. · British Journal of Haematology · 2019 · 14 citations · Full text